Need Support?

Donate
Donate

Newborn Screening

Transforming Lives Through Early Detection

Newborn Screening for Niemann-Pick Diseases

Newborn screening is a vital public health program designed to detect serious but treatable conditions in infants, often before symptoms appear. For families impacted by Niemann-Pick diseases, early diagnosis through newborn screening could be transformative, enabling timely interventions that improve quality of life and long-term outcomes.

Niemann-Pick diseases types A and B (acid sphingomyelinase deficiency or ASMD) and type C are rare, life-limiting conditions caused by genetic mutations. Symptoms can vary widely and often go undiagnosed until irreversible damage has occurred. With newborn screening:

  • Early Diagnosis: Infants can be diagnosed before symptoms appear, reducing diagnostic delays.
  • Proactive Management: Early identification enables better symptom monitoring, medical care, and access to emerging treatments.
  • Family Planning and Support: Screening provides families with critical information, enabling them to access genetic counseling and support services.

Global Progress and UK Opportunities

Current Landscape of Newborn Screening

Unfortunately Niemann-Pick diseases are not currently included in the UK’s newborn screening program. However, other countries, such as the United States, are beginning to pilot and include certain types of Niemann-Pick in their screening panels. Advances in testing methods, including enzyme assays and genetic testing, are increasing the feasibility of detecting Niemann-Pick diseases in newborns.

Championing Change for Niemann-Pick Families

Advocating for Inclusion in the UK

Niemann-Pick UK is dedicated to advocating for the inclusion of Niemann-Pick diseases in the UK’s newborn screening program. As a founding member group of the UK LSD Collaborative we are actively:

  • Collaborating with Stakeholders: Working with healthcare professionals, researchers, and policymakers to demonstrate the importance of screening.
  • Raising Awareness: Highlighting the benefits of newborn screening for Niemann-Pick diseases to the wider public and health authorities, through projects like A Rare Find (2023).
  • Driving Research: Supporting studies that demonstrate the clinical and economic benefits of early detection.

Join Our Mission for Early Detection

How You Can Help

Advancing newborn screening for Niemann-Pick diseases requires collective effort. You can help by:

  • Joining Our Campaigns: Support our efforts to include Niemann-Pick in the UK newborn screening panel.
  • Sharing Your Story: Personal experiences from families affected by Niemann-Pick diseases are powerful tools for advocacy.
  • Donating to Support Research and Awareness: Your contributions help us fund research and campaigns to bring this life-saving tool to families across the UK.

Related Content

You Might Also Be Interested In…